|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vaiopoulos AG, Athanasoula KC and
Papavassiliou AG: Epigenetic modifications in colorectal cancer:
Molecular insights and therapeutic challenges. Biochim Biophys
Acta. 1842:971–980. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Watson AJM and Collins PD: Colon cancer: A
civilization disorder. Dig Dis. 29:222–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee IM, Shiroma EJ, Lobelo F, Puska P,
Blair SN and Katzmarzyk PT: Lancet Physical Activity Series Working
Group: Effect of physical inactivity on major non-communicable
diseases worldwide: An analysis of burden of disease and life
expectancy. Lancet. 380:219–229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fearon ER, Pardoll DM, Itaya T, Golumbek
P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B and Frost P:
Interleukin-2 production by tumor cells bypasses T helper function
in the generation of an antitumor response. Cell. 60:397–403. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Basu S, Haase G and Ben-Ze'ev A: Wnt
signaling in cancer stem cells and colon cancer metastasis.
F1000Res. 19:52016.
|
|
8
|
Giles RH, van Es JH and Clevers H: Caught
up in a wnt storm: Wnt signaling in cancer. Biochim Biophys Acta.
1653:1–24. 2003.PubMed/NCBI
|
|
9
|
Capdevila J and Belmonte lzpisúa JC:
Extracellular modulation of the Hedgehog, Wnt and TGF-beta
signalling pathways during embryonic development. Curr Opin Genet
Dev. 9:427–433. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tanaka S, Terada K and Nohno T: Canonical
Wnt signaling is involved in switching from cell proliferation to
myogenic differentiation of mouse myoblast cells. J Mol Signal.
6:122011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen S, Guttridge DC, You Z, Zhang Z,
Fribley A, Mayo MW, Kitajewski J and Wang CY: WNT-1 Signaling
Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated
Transcription. J Cell Biol. 152:87–96. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cadigan KM and Nusse R: Wnt signaling: A
common theme in animal development. Genes Dev. 11:3286–3305. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai X, Wang L, Zhang L, Han Y, Yang G and
Li L: The expression and mutation of beta-catenin in colorectal
traditional serrated adenomas. Indian J Pathol Microbiol.
55:288–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Muller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang XJ, Reyes JL, Chua NH and Gaasterland
T: Prediction and identification of Arabidopsis thaliana microRNAs
and their mRNA targets. Genome Biol. 5:E652004. View Article : Google Scholar
|
|
17
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Michael MZ, SM OC, van Holst Pellekaan NG,
Young GP and James RJ: Reduced accumulation of specific microRNAs
in colorectal neoplasia. Mol Cancer Res. 1:882–891. 2003.PubMed/NCBI
|
|
19
|
Fan D, Lin X, Zhang F, Zhong W, Hu J, Chen
Y, Cai Z, Zou Y, He X, Chen X, et al: MicroRNA 26b promotes
colorectal cancer metastasis by down-regulating pten and wnt5a.
Cancer Sci. 109:354–362. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hashimi ST, Fulcher JA, Chang MH, Gov L,
Wang S and Lee B: MicroRNA profiling identifies miR-34a and miR-21
and their target genes JAG1 and WNT1 in the coordinate regulation
of dendritic cell differentiation. Blood. 114:404–414. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang S, Zhang L, Yang P, Chen P and Xie
Y: HCV core protein-induced down-regulation of microRNA-152
promoted aberrant proliferation by targeting Wnt1 in HepG2 cells.
PLOS One. 9:e817302014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Si W, Li Y, Shao H, Hu R, Wang W, Zhang K
and Yang Q: MiR-34a Inhibits Breast Cancer Proliferation and
Progression by Targeting Wnt1 in Wnt/β-catenin Signaling Pathway.
Am J Med Sci. 352:191–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kinzler KW and Vogelstein B: Lessons from
hereditary colorectal cancer. Cell. 87:159–170. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Williams LV, Veliceasa D, Vinokour E and
Volpert OV: miR-200b inhibits prostate cancer EMT, growth and
metastasis. PLoS One. 8:e839912013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei W, Chua MS, Grepper S and So SK:
Blockade of Wnt-1 signaling leads to anti-tumor effects in
hepatocellular carcinoma cells. Mol Cancer. 8:762009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carthew RW and Sontheimer EJ: Origins and
Mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Porter AG and Janicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Scholzen T and Gerdes J: The Ki-67
protein: From the known and the unknown. J Cell Physiol.
182:311–322. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao ZH, Lu C, Wang MX, Han Y and Guo LJ:
Differential β-catenin expression levels are associated with
morphological features and prognosis of colorectal cancer. Oncol
Lett. 8:2069–2076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leskela S, Leandro-Garcia LJ, Mendiola M,
Barriuso J, Inglada-Perez L, Munoz I, Martinez-Delgado B, Redondo
A, de Santiago J, Robledo M, et al: The miR-200 family controls
beta-tubulin III expression and is associated with paclitaxel-based
treatment response and progression-free survival in ovarian cancer
patients. Endocr Relat Cancer. 18:85–95. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yao Y, Hu J, Shen Z, Yao R, Liu S, Li Y,
Cong H, Wang X, Qiu W and Yue L: MiR-200b expression in breast
cancer: A prognostic marker and act on cell proliferation and
apoptosis by targeting Sp1. J Cell Mol Med. 19:760–769. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He B, You L, Uematsu K, Xu Z, Lee AY,
Matsangou M, Mccormick F and Jablons DM: A monoclonal antibody
against Wnt-1 induces apoptosis in human cancer cells. Neoplasia.
6:7–14. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Humphries B and Yang C: The microRNA-200
family: Small molecules with novel roles in cancer development,
progression and therapy. Oncotarget. 6:6472–6498. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ghavami S, Hashemi M, Ande SR, Yeganeh B,
Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ and
Los M: Apoptosis and cancer: Mutations within caspase genes. J Med
Genet. 46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Boatright KM and Salvesen GS: Mechanisms
of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bruno S and Darzynkiewicz Z: Cell cycle
dependent expression and stability of the nuclear protein detected
by Ki-67 antibody in HL-60 cells. Cell Prolif. 25:31–40. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rafael S, Veganzones S, Vidaurreta M, de
la Orden V and Maestro ML: Effect of β-catenin alterations in the
prognosis of patients with sporadic colorectal cancer. J Cancer Res
Ther. 10:591–596. 2014.PubMed/NCBI
|
|
40
|
Jung YS, Jun S, Lee SH, Sharma A and Park
JI: Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.
Oncotarget. 6:37257–37268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen DQ, Pan BZ, Huang JY, Zhang K, Cui
SY, De W, Wang R and Chen LB: HDAC 1/4-mediated silencing of
microRNA-200b promotes chemoresistance in human lung adenocarcinoma
cells. Oncotarget. 5:3333–3349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kolesnikoff N, Attema JL, Roslan S, Bert
AG, Schwarz QP, Gregory PA and Goodall GJ: Specificity protein 1
(Sp1) maintains basal epithelial expression of the miR-200 family:
Implications for epithelial-mesenchymal transition. J Biol Chem.
289:11194–11205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Manavalan TT, Teng Y, Litchfield LM,
Muluhngwi P, Al-Rayyan N and Klinge CM: Reduced expression of
miR-200 family members contributes to antiestrogen resistance in
LY2 human breast cancer cells. PLOS One. 8:e623342013. View Article : Google Scholar : PubMed/NCBI
|
